论文部分内容阅读
全球每年肺癌发病1 300 000例,死亡1 000 000例[1]。非小细胞肺癌(NSCLC)约占肺癌总发病率的80%左右,局部晚期(Ⅲ期)NSCLC占临床就诊NSCLC患者的40%,是一种异质性很大的疾病,其中除一少部分可手术,其余大部分
There are 1 300 000 lung cancer cases worldwide and 1 000 deaths each year [1]. Non-small cell lung cancer (NSCLC) accounts for about 80% of the total incidence of lung cancer, locally advanced (Ⅲ) NSCLC accounts for 40% of clinical treatment of NSCLC patients, is a heterogeneous disease, except for a small part Can be surgery, most of the rest